biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > We're tied, poof! Lookie dat!

<< Previous

Bullboard Posts

Next >>

Post by Boomskidon Jan 16, 2023 8:46pm

186 Views

Post# 35226913

We're tied, poof! Lookie dat!

694 to 693. Close enough between friends.

That's a lotta thumbs, poof.

I should add the hundred or two I got as JDavenport after the deal was announced.

I'm headed to a thousand, poof!

Holy moly!

Isn't this a fun race?!

Thumbidee doo dah, thumbidee day,

JD Thumbs

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute